Advertise on podcast: Bioethics for the People

In this introduction to Inked by Faith, we begin the story of Operation Tat-Type, a Cold War civil defense program that blood-typed and tattooed thousands of Americans in the early 1950s, including children. The series begins with a family discovery: a grandmother’s tattoo; never hidden, just never talked about. From there, we ask a larger question—not about secrets or conspiracies, but about how communities normalize extraordinary measures in moments of fear… and how those memories fade. This episode sets the stage for the stories still waiting to be told.

Devan and Tyler catch up after a busy few months. For the past several months, listeners have been asking the same questions: Did you quit? Are you guys fighting? Did the podcast die? The answer is no, no, and no. We’ve been working on a limited series that takes us deep into a particular moment in medical history. A moment with long shadows. Legal consequences. Ethical fault lines. Human impact that still echoes. This time, we’re not just talking. We’re investigating and reporting. In archives. In communities. In stories that haven’t been told this way before. This project has taken time because it demands care—care for the history, for the people involved, and for the complexity of the ethical questions it raises. We’re almost ready to share it. Stay tuned in 2026.

In this episode, Tyler and Devan talk with Ray Moseley and Marcia Brown, both from the University of Florida School of Medicine. Ray and Marcia talk about their pilot project that looked at how accurately an AI tool can predict the medical decisions of a patient, compared with a family member or surrogate. The outcomes are surprising.

In this episode Drs. Kostick-Quenet and Blumenthal-Barby discuss their research on LVADs and AI and their thoughts on how to use AI in clinical ethics.

In this episode we talk with Dr. Benjamin Collins about combating bias in AI.

In this episode, focused on the utilization of AI and Machine Learning in healthcare, Tyler and Devan talk to Teresa Fair-Field, OTD, OTR, who is part of an NIH-funded team developing "Emma Baby," a smartphone application designed to detect critical motor markers in infants during their first year. Read More Here: Fair-Field, T., & Modayur, B. (2025). Clinical validation of an abridged AIMS: Streamlining motor screening in the first-year infant. Early Human Development, 202, Article 106207. https://doi.org/10.1016/j.earlhumdev.2025.106207 Fair-Field, T., & Modayur, B. (2025). Clinical validation of an abridged AIMS: Streamlining motor screening in the first-year infant. Early Human Development, 202, Article 106207. https://doi.org/10.1016/j.earlhumdev.2025.106207

In this episode we interview Dr. Lukas J. Meier about an algorithm he helped develop to help solve clinical ethics dilemmas.

In this episode we talk with Dr. Jeffrey P. Bishop about how AI will shape our minds and habits and how we need to rethink medical training in light of the promises and perils of AI in health care.

In this episode, we chat with Drs. Ami Palmer and David Schwan to discuss the wild west of mental health and wellness apps using AI.

In this episode Devan and Tyler discuss the most common ethical concerns raised in the field of AI and clinical care.

In this episode Devan and Tyler discuss the current uses of AI in clinical medicine.

In this episode, Tyler and Devan are joined by Dr. Holland Kaplan to unpack a case of sudden-onset psychosis. We discuss the complex interplay between patient autonomy, surrogate decision-making, and the nuance of invasive interventions over a patient’s objection. How do we assess decision-making capacity in an acutely altered state? What happens when a surrogate’s wishes conflict with what clinicians believe is medically necessary? And where should the line be drawn between beneficence and coercion?

Devan and Tyler sit down with Dr. David Shalowitz to unpack the ethical complexities surrounding the claim that clinical trials offer the best care for cancer patients. From the “therapeutic misconception” to the burdens and risks of trial participation, we explore what it means to balance patient-centered care with the pursuit of scientific advancement. David Shalowitz, “Are Patients with Cancer Care Best Managed in a Clinical Trial?” JAMA 331 (24): 2077-2078.

In this episode, Tyler and Devan are joined by Dr. Peter DePergola to explore policies addressing non-beneficial treatment requests, medical futility, and inappropriate treatment demands. Dr. DePergola, the Shaughness Family Chair for the Study of the Humanities at Elms College, is an Associate Professor of Bioethics and Medical Humanities with joint appointments in Philosophy, Religious Studies, and Biomedical Sciences. He also serves as Director of the Undergraduate and Graduate Bioethics and Medical Humanities Programs and Executive Director of the Saint Augustine Center for Ethics, Religion, and Culture. Dr. DePergola shares insights from his recent policy revision work, focusing on refining the concepts and language surrounding non-beneficial treatment, futility, and related ethical challenges in medical decision-making.